A subsidiary of Switzerland-based pharmaceutical giant Novartis is making a major investment in central Indiana. Advanced Accelerator Applications plans to build a $72 million production facility at the Purdue Research Park of Indianapolis. A critical business connection in West Lafayette played a key role in landing the deal. Advanced Accelerator Applications General Manager Mike Rossi explains in this week’s Business of Health.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}